Novel R21 vaccine provides hope to save children from malaria in Africa, but more work needs to be done
Krisztian Magori reports on the exciting new results of a phase II clinical trial of the R21 malaria vaccine, which shows safety and high levels of efficacy, potentially providing us with the tool necessary to control and eradicate malaria once and for all.